Abstract

Sudden death is the most common mode of mortality in patients with heart failure and preserved ejection fraction (HFpEF). Ventricular arrhythmias (VA) have been suspected as the etiology but the supporting evidence in patients with HFpEF is scarce. We sought to investigate VA prevalence, and to determine if VA are associated with prolonged repolarization, in patients with HFpEF. In a retrospective case-control study design, Cedars-Sinai patients who underwent prolonged ambulatory electrocardiographic monitoring (Zio Patch) between 2016 and 2018 were screened for a clinical diagnosis of HFpEF. Patients with normal diastolic and systolic function who underwent Zio Patch monitoring were also reviewed as controls. Multivariable logistic regression was used to compare the prevalence of rhythm disturbances in patients with and without HFpEF. Ventricular tachycardia (VT) was more prevalent in patients with HFpEF (37% vs. 16% in controls, p = 0.001). Most episodes were non-sustained except for one case of sustained VT in a patient with HFpEF. Covariate-adjusted logistic regression including HFpEF diagnosis, age, sex, body mass index, and the presence of comorbidities revealed that only HFpEF was associated with increased risk of VT (relative risk 2.86, p = 0.023). Subgroup-analyses revealed an association between increased QTc interval and risk of VT (460 ± 38 ms in HFpEF patients with VT vs. 445 ± 28 ms in HFpEF patients without VT, p = 0.03). Non-sustained VT was more prevalent in patients with HFpEF compared to patients without HFpEF, and QTc interval prolongation was associated with VT in HFpEF.

Highlights

  • Heart failure and preserved ejection fraction (HFpEF) is increasing in incidence, rivaling heart failure and reduced ejection fraction (HFrEF) [1, 2]

  • PR interval and QTc interval were more prolonged in patients with HFpEF compared to controls

  • QTc interval was more prolonged in HFpEF patients with Ventricular tachycardia (VT) compared to HFpEF patients without VT (460 ± 38 ms vs. 445 ± 28 ms, p = 0.032). In this retrospective case control study, non-sustained VT was more prevalent in patients with HFpEF compared to patients without HFpEF

Read more

Summary

Introduction

Heart failure and preserved ejection fraction (HFpEF) is increasing in incidence, rivaling heart failure and reduced ejection fraction (HFrEF) [1, 2]. Patients with HF have a poor prognosis, with a 75% mortality rate at 5 years, regardless of EF [3]. Unlike HFrEF, for which numerous medical and device therapies have been proven to reduce mortality, no treatment has been. Medical Research Program of the US Department of Defense (PR150620 to EM). The sponsors played no role in the the study design, data collection and analysis, decision to publish, or preparation of the manuscript

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call